BioSpace Movers & Shakers, April 10
| BioSpace

Bolt Biotherapeutics – Edith Perez was named CMO of Bolt Therapeutics. Perez has held positions within AACR, ASCO and the NCI. Perez will maintain a clinical affiliation as Professor of Medicine at the Mayo Clinic and director of the Mayo Clinic Breast Cancer Translational Genomics Program, where she has practiced for two decades. Prior to joining […]

Chutes & Ladders—Immunomedics taps Ipsen exec Semerjian as CEO
| FierceBiotech

Semerjian, who comes from being Ipsen’s chief commercial officer and executive vice president and also served a major 16-year stint at Novartis Oncology, will now head up the biotech as it looks to the summer for a potential approval after one of the most tortuous paths in biotech lore. There is a long history here that […]

NeuBase Sets a Course for the Clinic
| GEN Edge News

Pittsburgh developer of next-gen antisense oligonucleotide therapies says data generated from a pharmacokinetic study in non-human primates (NHPs) and in vitro pharmacodynamics studies in patient-derived Huntington’s disease (HD) cell lines supports its decision to advance the development of its lead programs in Huntington’ disease and myotonic dystrophy type 1, and expand its pipeline into other indications . […]